BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12898362)

  • 1. Poorly controlled ulcerative colitis treated by colectomy during remission induced by extracorporeal leukocyte removal therapy.
    Fukunaga K; Fukuda Y; Sawada K; Hori K; Matoba Y; Sagayama K; Ohnishi K; Fukui S; Shimoyama T
    J Gastroenterol; 2003; 38(7):684-9. PubMed ID: 12898362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect and safety of granulocyte-monocyte adsorption apheresis for patients with ulcerative colitis positive for cytomegalovirus in comparison with immunosuppressants.
    Yoshino T; Nakase H; Matsuura M; Matsumura K; Honzawa Y; Fukuchi T; Watanabe K; Murano M; Tsujikawa T; Fukunaga K; Matsumoto T; Chiba T
    Digestion; 2011; 84(1):3-9. PubMed ID: 21311190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Leukocytapheresis for ulcerative colitis].
    Fukunaga K; Sawada K; Chikano S; Ohnishi K; Egashira A; Tanaka J; Nagase K; Satomi M; Shimoyama T
    Nihon Rinsho; 1999 Nov; 57(11):2496-502. PubMed ID: 10572419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocytapheresis therapy for steroid-naïve patients with active ulcerative colitis: its clinical efficacy and adverse effects compared with those of conventional steroid therapy.
    Nishioka C; Aoyama N; Maekawa S; Shirasaka D; Nakahara T; Tamura T; Fukagawa M; Umezu M; Abe T; Kasuga M
    J Gastroenterol Hepatol; 2005 Oct; 20(10):1567-71. PubMed ID: 16174075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis.
    Kanke K; Nakano M; Hiraishi H; Terano A
    Dig Liver Dis; 2004 Dec; 36(12):811-7. PubMed ID: 15646427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study.
    Sakata Y; Iwakiri R; Amemori S; Yamaguchi K; Fujise T; Otani H; Shimoda R; Tsunada S; Sakata H; Ikeda Y; Ando T; Nakafusa Y; Fujimoto K
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):629-33. PubMed ID: 18679064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocytapheresis versus methylprednisolone in patients with acute ulcerative colitis: 12-month follow up.
    Bresci G; Parisi G; Mazzoni A; Scatena F; Capria A
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1678-82. PubMed ID: 18823440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.
    Tanaka T; Okanobu H; Yoshimi S; Murakami E; Kogame A; Imagawa H; Numata Y; Kuga Y; Moriya T; Ohya T; Kajiyama G
    Dig Liver Dis; 2008 Sep; 40(9):731-6. PubMed ID: 18387860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal leukocyte removal therapy for patients with ulcerative colitis.
    Kumagai M; Yamato Y; Maeda K; Nakashima E; Ushijima K; Kimura A
    Pediatr Int; 2007 Aug; 49(4):431-6. PubMed ID: 17587263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis.
    Naganuma M; Funakoshi S; Sakuraba A; Takagi H; Inoue N; Ogata H; Iwao Y; Ishi H; Hibi T
    Inflamm Bowel Dis; 2004 May; 10(3):251-7. PubMed ID: 15290920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting short- and long-term effects of leukocyte removal therapy in active ulcerative colitis.
    Nakano R; Iwakiri R; Ikeda Y; Kishi T; Tsuruoka N; Shimoda R; Sakata Y; Yamaguchi K; Fujimoto K
    J Gastroenterol Hepatol; 2013 Feb; 28(2):303-8. PubMed ID: 23339387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors of efficacy of leukocytapheresis for steroid-resistant ulcerative colitis patients.
    Takemoto K; Kato J; Kuriyama M; Nawa T; Kurome M; Okada H; Sakaguchi K; Shiratori Y
    Dig Liver Dis; 2007 May; 39(5):422-9. PubMed ID: 17379587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study of leukocytapheresis efficacy with 1.5 liter blood processing volume in patients with ulcerative colitis.
    Shimada M; Iwase H; Tsuzuki T; Hirashima N; Kobayashi K; Hibino Y; Watanabe H; Ryuge N; Ando T; Goto H; Yagi Y; Tsujikawa T; Andoh A
    Ther Apher Dial; 2008 Oct; 12(5):368-73. PubMed ID: 18937719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocytapheresis in ulcerative colitis: results of a multicenter double-blind prospective case-control study with sham apheresis as placebo treatment.
    Sawada K; Kusugami K; Suzuki Y; Bamba T; Munakata A; Hibi T; Shimoyama T
    Am J Gastroenterol; 2005 Jun; 100(6):1362-9. PubMed ID: 15929771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocytapheresis in steroid-dependent and steroid-resistant patients with inflammatory bowel disease: a prospective observational study.
    Sacco R; Romano A; Mazzoni A; Bertini M; Federici G; Metrangolo S; Parisi G; Nencini C; Giampietro C; Bertoni M; Tumino E; Scatena F; Bresci G
    J Crohns Colitis; 2013 Dec; 7(12):e692-7. PubMed ID: 23870727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Leukocytapheresis for ulcerative colitis].
    Sawada K; Ohnishi K; Kosaka T; Egashira A; Yamamura M; Satomi M; Shimoyama T
    Nihon Geka Gakkai Zasshi; 1997 Apr; 98(4):438-42. PubMed ID: 9168498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of five days of consecutive leukocytapheresis for the treatment of ulcerative colitis: a preliminary study.
    Tsujikawa T; Andoh A; Ogaẃa A; Sonoda A; Yagi Y; Hata K; Sasaki M; Saito Y; Fujiyama Y
    Ther Apher Dial; 2009 Feb; 13(1):14-8. PubMed ID: 19379165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study.
    Hanai H; Watanabe F; Takeuchi K; Iida T; Yamada M; Iwaoka Y; Saniabadi A; Matsushita I; Sato Y; Tozawa K; Arai H; Furuta T; Sugimoto K; Bjarnason I
    Clin Gastroenterol Hepatol; 2003 Jan; 1(1):28-35. PubMed ID: 15017514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between ulcerative colitis patients treated with leukocytapheresis and ulcerative colitis-associated colorectal cancer.
    Kinugasa T; Akagi Y; Murotani K; Romeo K; Yoshida T; Ryu Y; Shiratuchi I; Shirouzu K
    Anticancer Res; 2011 Jul; 31(7):2547-52. PubMed ID: 21873173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term colectomy rate after intensive intravenous corticosteroid therapy for ulcerative colitis prior to the immunosuppressive treatment era.
    Gustavsson A; Halfvarson J; Magnuson A; Sandberg-Gertzén H; Tysk C; Järnerot G
    Am J Gastroenterol; 2007 Nov; 102(11):2513-9. PubMed ID: 17680849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.